默沙东 Eliav Barr 将出席伦敦 Jefferies 全球医疗大会，11月19日参加炉边谈话
默沙东（Merck，纽约证券交易所代码：MRK）11月12日宣布，默沙东研究实验室高级副总裁、全球临床开发主管兼首席医学官 Eliav Barr 博士将出席在英国伦敦举行的 Jefferies 全球医疗大会，参加定于11月19日举行的炉边谈话。默沙东总部位于美国新泽西州 Rahway，在美国与加拿大以外地区以 MSD 之名运营。
这场炉边谈话定于伦敦时间11月19日（周四）上午11时举行，即美东时间当天上午6时。投资人、分析师、媒体与公众可通过默沙东的投资者渠道收听这场谈话的现场音频直播。
Jefferies 全球医疗大会伦敦站今年于11月16日至19日举行，汇集全球医疗健康行业的管理层与投资人。默沙东表示，公司以领先的科学挽救与改善全球生命为宗旨，专注创新药物与疫苗的研发与交付，Barr 负责其全球临床开发工作。
Merck's Eliav Barr to Take Part in Fireside Chat at Jefferies Global Healthcare Conference in London on Nov. 19
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced on November 12 that Dr. Eliav Barr, senior vice president, head of global clinical development and chief medical officer at Merck Research Laboratories, is scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 19. Merck is headquartered in Rahway, New Jersey.
The fireside chat is scheduled for Thursday, November 19, 2026, at 11:00 a.m. GMT, or 6:00 a.m. ET. Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the session through Merck's investor channels.
The London edition of the Jefferies Global Healthcare Conference runs from November 16 to 19 this year, bringing together management teams and investors from across the global healthcare industry. Merck says it is focused on using leading-edge science to save and improve lives around the world through innovative medicines and vaccines, and Barr leads its global clinical development work.
来源：默沙东公司
发布：GSM·美国（发布链接）
图片来源：图：默沙东研究实验室位于加州 South San Francisco 的大楼。Coolcaesar 摄，CC BY-SA 4.0，经 Wikimedia Commons。 / Photo: Merck Research Laboratories building in South San Francisco, California. Photo by Coolcaesar, CC BY-SA 4.0, via Wikimedia Commons.
GSM Global · 本篇英文版 English edition of this story
